![Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial - The Lancet Oncology Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/9b4180f6-0d2e-4631-b126-8a4a309031e5/gr2_lrg.jpg)
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial - The Lancet Oncology
![0339 ) MARCO ANTONETTO NORMALINE ERBE 60CPR by ( 0339 ) MARCO ANTONETTO : Amazon.de: Drogerie & Körperpflege 0339 ) MARCO ANTONETTO NORMALINE ERBE 60CPR by ( 0339 ) MARCO ANTONETTO : Amazon.de: Drogerie & Körperpflege](https://m.media-amazon.com/images/I/51weptcKWXL._SR600%2C315_PIWhiteStrip%2CBottomLeft%2C0%2C35_SCLZZZZZZZ_FMpng_BG255%2C255%2C255.jpg)
0339 ) MARCO ANTONETTO NORMALINE ERBE 60CPR by ( 0339 ) MARCO ANTONETTO : Amazon.de: Drogerie & Körperpflege
Cédric Heidet - Responsable Marketing Oncologie Thoracique - LABORATOIRES LEURQUIN MEDIOLANUM | LinkedIn
Cédric Heidet - Responsable Marketing Oncologie Thoracique - LABORATOIRES LEURQUIN MEDIOLANUM | LinkedIn
![Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design - Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design -](https://www.thelancet.com/cms/attachment/9e55710b-8646-4603-ad30-4851bb359b8e/gr1_lrg.gif)